Skip to main content

Table 3 Summary of number of clinical trials divided into cancer type and stage of disease

From: Clinical translation of patient-derived tumour organoids- bottlenecks and strategies

Type of Cancer

Early/ Locally Advanced

(n =)

Refractory/ Metastatic

(n =)

All Stages

(n =)

Total Number of Studies

Percentage of Total Studies (%)

Breast Cancer

5

6

1

12

15.8

Pancreatic Cancer

3

3

4

10

13.1

Colorectal Cancer

3

3

3

9

11.8

Lung Cancer

2

2

4

8

10.5

Different Gastrointestinal Cancers

3

2

0

5

6.6

Esophageal Cancer

1

2

0

3

3.9

Biliary Tract Cancer

2

1

0

3

3.9

Kidney Cancer

2

1

0

3

3.9

Ovarian Cancer

0

2

1

3

3.9

Different Reproductive Cancers

1

2

0

3

3.9

Any Cancer Type

0

3

1

4

5.3

Liver Cancer

1

1

0

2

2.6

Glioblastoma

1

1

0

2

2.6

Neuroendocrine Carcinoma

0

1

1

2

2.6

Sarcoma

1

1

0

2

2.6

Different Head and Neck Cancers

1

0

1

2

2.6

Multiple Myeloma

0

0

1

1

1.3

Prostatic Cancer

0

1

0

1

1.3

Bladder Cancer

1

0

0

1

1.3